PhoreMost has built a pipeline of novel targets and early drug discovery programs using its next-generation “SITESEEKER®” phenotypic screening platform
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.
